[Multicenter randomized controlled study of temozolomide versus semustine in the treatment of recurrent malignant glioma].

Sun, Jian

[Multicenter randomized controlled study of temozolomide versus semustine in the treatment of recurrent malignant glioma]. [electronic resource] - Zhonghua yi xue za zhi Jan 2013 - 165-8 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

0376-2491


Adult
Astrocytoma--drug therapy
Dacarbazine--adverse effects
Female
Glioblastoma--drug therapy
Glioma--drug therapy
Humans
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Semustine--adverse effects
Temozolomide